Oncology nurse training in cancer genetics

Editor—The rapid increase in understanding of cancer genetics in recent years means that few oncology nurses have sufficient knowledge to address the issues of patients concerned about inherited predisposition to cancer.1-3 While some nursing curricula have recently incorporated cancer genetics, this does not assist the large body of oncology nurses already in practice. The need for an educational programme in cancer genetics was highlighted locally by a focus group of senior level nurses and social workers practising in oncology (unpublished data). All felt inadequately equipped to deal with enquiries regarding family history and cancer risk from patients and staff. Nobody in the focus group was aware of the Australian protocols for referral to familial cancer clinics within their employing organisations and family history was not routinely collected. The Australian guidelines categorise families according to their level of cancer risk (“high”, “moderate”, or “low”) based on family history and/or the presence of a germline mutation known to predispose to cancer.4 In Australia, multidisciplinary Familial Cancer Centres provide genetic counselling, genetic testing, and risk management advice to those families judged to be at “high risk”. Those categorised at low or moderate inherited risk of cancer may also benefit from informed counselling but may not meet the criteria for referral to the Familial Cancer Centres. As cancers are common, a significant number of people in the community with a family history of cancer will be in these categories. Many will not have a single gene mutation, but are at somewhat increased risk of developing cancer and require surveillance advice.5-7 The person's perception of this risk may not reflect reality. People at moderate risk for breast cancer often overestimate their level of risk.8-10After receiving counselling and a personal risk estimate, most report feeling less worried and their …

[1]  B. Halliwell Free radicals and antioxidants: a personal view. , 2009, Nutrition reviews.

[2]  F. Penault-Llorca,et al.  Prophylactic oophorectomy , 2003, Cancer.

[3]  U. Tantravahi Prenatal screening for cystic fibrosis. , 2002, Medicine and health, Rhode Island.

[4]  T. Volm Familial ovarian cancer. , 2002, Current women's health reports.

[5]  P. Butow,et al.  Risk perceptions and knowledge of breast cancer genetics in women at increased risk of developing hereditary breast cancer , 2001 .

[6]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[7]  N. Hallowell A qualitative study of the information needs of high‐risk women undergoing prophylactic oophorectomy , 2000, Psycho-oncology.

[8]  S. Zubrick,et al.  Population screening for cystic fibrosis in Western Australia: community response. , 2000, American journal of medical genetics.

[9]  T. Marteau Population screening for cystic fibrosis: a research agenda for the next 10 years. , 2000, American journal of medical genetics.

[10]  R. Croyle,et al.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. , 2000, Preventive medicine.

[11]  T. Crow,et al.  Update on chromosomal locations for psychiatric disorders: report of the interim meeting of chromosome workshop chairpersons from the VIIth World Congress of Psychiatric Genetics, Monterey, California, October 14-18, 1999. , 2000, American journal of medical genetics.

[12]  T. Crow,et al.  Failure to establish linkage on the X chromosome in 301 families with schizophrenia or schizoaffective disorder. , 2000, American journal of medical genetics.

[13]  P. Devilee,et al.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.

[14]  M. Partington,et al.  Investigation of meiotic rearrangements in DGS/VCFS patients with a microdeletion 22q11.2 , 2000, Journal of medical genetics.

[15]  K. Devriendt,et al.  Prenatal diagnosis of inherited satellited non‐acrocentric chromosomes , 2000, Prenatal diagnosis.

[16]  Julie O. Culver,et al.  Genetic counseling for women with an intermediate family history of breast cancer. , 2000, American journal of medical genetics.

[17]  Matthew W. Darlison,et al.  Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry , 2000, BMJ : British Medical Journal.

[18]  A. Wilde,et al.  A single Na(+) channel mutation causing both long-QT and Brugada syndromes. , 1999, Circulation research.

[19]  Suzanne M. Miller,et al.  Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. , 1999, Gynecologic oncology.

[20]  D. Ledbetter,et al.  Satellited chromosome 10 detected prenatally in a fetus and confirmed as mosaic in a parent , 1999, Prenatal Diagnosis.

[21]  Priya D. Duggal,et al.  Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. , 1999, American journal of medical genetics.

[22]  P. Butow,et al.  Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. , 1999, Gynecologic oncology.

[23]  M. Patton,et al.  Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. , 1999, Circulation.

[24]  N. Hallowell Doing the right thing: genetic risk and responsibility , 1999 .

[25]  O. Olopade,et al.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.

[26]  A. Jervell,et al.  CONGENITAL DEAF‐MUTISM, FUNCTIONAL HEART DISEASE WITH PROLONGATION OF THE Q‐T INTERVAL, AND SUDDEN DEATH , 1999, American heart journal.

[27]  D M Roden,et al.  Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. , 1999, Circulation.

[28]  M. Keating,et al.  MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia , 1999, Cell.

[29]  W. Haverkamp,et al.  The LQT syndromes – current status of molecular mechanisms , 1999, Zeitschrift für Kardiologie.

[30]  C. Steinlein,et al.  Ectopic NORs on human chromosomes 4qter and 8q11: rare chromosomal variants detected in two families , 1999, Journal of medical genetics.

[31]  A. Munnich,et al.  Prenatal diagnosis of a satellited non‐acrocentric chromosome derived from a maternal translocation (10;13)(p13;p12) and review of literature , 1999, Prenatal diagnosis.

[32]  P. Coumel,et al.  Genomic organization of the KCNQ1 K+ channel gene and identification of C-terminal mutations in the long-QT syndrome. , 1999, Circulation research.

[33]  M. Sigman,et al.  Conventional and Molecular Cytogenetic Identification of a Variant Klinefelter Syndrome Patient with a Deleted X Chromosome , 1999, Pathobiology.

[34]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[35]  M. Modell,et al.  A multidisciplinary approach for improving services in primary care: randomised controlled trial of screening for haemoglobin disorders , 1998, BMJ.

[36]  T. Crow,et al.  Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome. , 1998, American journal of medical genetics.

[37]  K. Naruse,et al.  Peroxide production and apoptosis in cultured cells carrying mtDNA mutation causing encephalomyopathy , 1998, Biochemistry and molecular biology international.

[38]  Yusuke Nakamura,et al.  Genomic organization and mutational analysis of KVLQT1, a gene responsible for familial long QT syndrome , 1998, Human Genetics.

[39]  Jeffrey C. Murray,et al.  Comprehensive human genetic maps: individual and sex-specific variation in recombination. , 1998, American journal of human genetics.

[40]  M. Keating,et al.  Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. , 1998, Genomics.

[41]  B. Kerem,et al.  An interstitial nucleolus organizer region in the long arm of human chromosome 7: cytogenetic characterization and familial segregation , 1998, Cytogenetic and Genome Research.

[42]  S. Priori,et al.  A recessive variant of the Romano-Ward long-QT syndrome? , 1998, Circulation.

[43]  N. Hallowell ‘You don’t want to lose your ovaries because you think ‘I might become a man' ’. Women's perceptions of prophylactic surgery as a cancer risk management option , 1998, Psycho-oncology.

[44]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[45]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[46]  J. Rapoport,et al.  Brief Report: Association of Sex Chromosome Anomalies With Childhood-Onset Psychotic Disorders , 1998 .

[47]  Joie Davis,et al.  The Role of the Nurse in Cancer Genetics , 1998, Cancer nursing.

[48]  T. Crow,et al.  The chromosome workshops at the 5th International Congress of Psychiatric Genetics--the weight of the evidence from genome scans. , 1998, Psychiatric genetics.

[49]  C. Moraes,et al.  A disease-associated G5703A mutation in human mitochondrial DNA causes a conformational change and a marked decrease in steady-state levels of mitochondrial tRNA(Asn) , 1997, Molecular and cellular biology.

[50]  P. Coumel,et al.  KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. , 1997, Circulation.

[51]  G. Breithardt,et al.  KCNE1 mutations cause Jervell and Lange-Nielsen syndrome , 1997, Nature Genetics.

[52]  M. Pembrey,et al.  IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. , 1997, Human molecular genetics.

[53]  M. Sanguinetti,et al.  Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.

[54]  A. Cao,et al.  Molecular Diagnosis and Carrier Screening for β Thalassemia , 1997 .

[55]  D. Page,et al.  Abnormal XY interchange between a novel isolated protein kinase gene, PRKY, and its homologue, PRKX, accounts for one third of all (Y+)XX males and (Y-)XY females. , 1997, Human molecular genetics.

[56]  K. Nicolaides,et al.  Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years , 1997, BMJ.

[57]  H. Neuenschwander,et al.  Audit of process of antenatal screening for sickle cell disorders at a north London hospital , 1997, BMJ.

[58]  M. Lazdunski,et al.  Properties of KvLQT1 K+ channel mutations in Romano–Ward and Jervell and Lange‐Nielsen inherited cardiac arrhythmias , 1997, The EMBO journal.

[59]  D. Craufurd,et al.  The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. , 1997, Journal of medical genetics.

[60]  R. Murray,et al.  A linkage study of schizophrenia to markers within Xp11 near the MAOB gene , 1997, Psychiatry Research.

[61]  M. Keating,et al.  Molecular basis of the long-QT syndrome associated with deafness. , 1997, The New England journal of medicine.

[62]  J. Jenkins Educational issues related to cancer genetics. , 1997, Seminars in oncology nursing.

[63]  D. Macdonald The oncology nurse's role in cancer risk assessment and counseling. , 1997, Seminars in oncology nursing.

[64]  D. Easton,et al.  Contribution of BRCA1 mutations to ovarian cancer. , 1997, The New England journal of medicine.

[65]  R. Cantor,et al.  PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population. , 1997, American journal of human genetics.

[66]  D. Schlessinger,et al.  Evolutionary features of the 4-Mb Xq21.3 XY homology region revealed by a map at 60-kb resolution. , 1997, Genome research.

[67]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[68]  A. Clarke,et al.  Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales The South Wales Cystic Fibrosis Carrier Screening Research Team , 1997, Clinical genetics.

[69]  A S Whittemore,et al.  Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. , 1997, American journal of human genetics.

[70]  E. Ernst,et al.  The BMJ's Nuremberg issue , 1997 .

[71]  A. Feinberg,et al.  Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements , 1997, Nature Genetics.

[72]  P. Coumel,et al.  A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.

[73]  G. Turner,et al.  Cystic fibrosis carrier screening in two New South Wales country towns. , 1996, The Medical journal of Australia.

[74]  A. Jauch,et al.  Mapping human telomere regions with YAC and P1 clones: chromosome-specific markers for 27 telomeres including 149 STSs and 24 polymorphisms for 14 proterminal regions. , 1996, Genomics.

[75]  J. Morse Interpreting qualitative data: Methods for analysing talk, text and interaction , 1996 .

[76]  P Coumel,et al.  Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome. , 1996, Journal of molecular and cellular cardiology.

[77]  S. Loader,et al.  Cystic fibrosis carrier population screening in the primary care setting. , 1996, American journal of human genetics.

[78]  N. Holtzman,et al.  Educating patients about cystic fibrosis carrier screening in a primary care setting. , 1996, Archives of family medicine.

[79]  Z. Li,et al.  Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. , 1996, Genomics.

[80]  R. Kuick,et al.  A methylated human 9-kb repetitive sequence on acrocentric chromosomes is homologous to a subtelomeric repeat in chimpanzees. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  B. Stoll Specialist breast and ovarian cancer clinics should be staffed by oncologist nurses , 1996, British medical journal.

[82]  B. Blumberg,et al.  Cystic fibrosis heterozygote screening in 5,161 pregnant women. , 1996, American journal of human genetics.

[83]  D. Craufurd,et al.  Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice. , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.

[84]  M. Schwartz,et al.  Psychological and social impact of carrier screening for cystic fibrosis among pregnant women — a pilot study , 1996, Clinical genetics.

[85]  J. vandeLaar,et al.  [Preconception screening for carrier state in cystic fibrosis; testing against Health Council's criteria for genetic screening]. , 1996 .

[86]  E. Clayton,et al.  Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. , 1996, American journal of human genetics.

[87]  O. Zuffardi,et al.  Mitotic recombination among acrocentric chromosomes' short arms , 1996, Annals of human genetics.

[88]  N. Affara,et al.  The sequence organization of Yp/proximal Xq homologous regions of the human sex chromosomes is highly conserved. , 1996, Genomics.

[89]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[90]  Ovarian cancer: Screening, treatment, and follow‐up , 1995 .

[91]  N. Siafakas,et al.  The Tay‐Sachs disease prevention program in Australia: Sydney pilot study , 1995, The Medical journal of Australia.

[92]  B. Chance,et al.  Extensive tissue oxygenation associated with mitochondrial DNA mutations. , 1995, Biochemical and biophysical research communications.

[93]  R. Lyle,et al.  The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. , 1995, Genomics.

[94]  S. Franceschi,et al.  Risk of cutaneous melanoma associated with a family history of the disease , 1995, International journal of cancer.

[95]  P. Arn,et al.  Reproductive outcome in 3 families with a satellited chromosome 4 with review of the literature. , 1995, American journal of medical genetics.

[96]  K. Calzone,et al.  Shorter hospital stays necessitate changes in breast cancer patient education. , 1995 .

[97]  K. Helzlsouer,et al.  Predictors of and satisfaction with bilateral prophylactic mastectomy. , 1995, Preventive medicine.

[98]  C. Pope,et al.  Qualitative Research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research , 1995 .

[99]  I. Dunham,et al.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. , 1995, American journal of human genetics.

[100]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[101]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[102]  L. Loescher Genetics in cancer prediction, screening, and counseling: Part II, The nurse's role in genetic counseling. , 1995, Oncology Nursing Forum.

[103]  T. Marteau,et al.  Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening , 1995, BMJ.

[104]  Robert C. Bast,et al.  Ovarian cancer: screening, treatment, and followup. , 1995, NIH consensus statement.

[105]  C. Hsieh,et al.  Satellited 4q identified in amniotic fluid cells. , 1995, American journal of medical genetics.

[106]  A. Moss,et al.  Polymorphism of the gene encoding a human minimal potassium ion channel (minK). , 1994, Gene.

[107]  J A Raeburn Controversies in Management: Screening before pregnancy is needed , 1994 .

[108]  M. Ferguson-Smith,et al.  A set of ninety-seven overlapping yeast artificial chromosome clones spanning the human Y chromosome euchromatin. , 1994, Genomics.

[109]  G. Evers‐Kiebooms,et al.  A stigmatizing effect of the carrier status for cystic fibrosis? , 1994, Clinical genetics.

[110]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[111]  N. Holtzman,et al.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. , 1994, American journal of human genetics.

[112]  A. Hajianpour,et al.  Genotype-phenotype correlation in satellited 1p chromosome: Importance of fluorescence in situ hybridization (FISH) applications , 1994 .

[113]  A. Poustka,et al.  Highly homologous loci on the X and Y chromosomes are hot–spots for ectopic recombinations leading to XX maleness , 1994, Nature Genetics.

[114]  T. Crow,et al.  Search for linkage to schizophrenia on the X and Y chromosomes. , 1994, American journal of medical genetics.

[115]  S. Raeburn Screening for carriers of cystic fibrosis , 1994, BMJ.

[116]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[117]  W. Droegemueller Screening for ovarian carcinoma: hopeful and wishful thinking. , 1994, American journal of obstetrics and gynecology.

[118]  D. Ward,et al.  Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer , 1994, Nature.

[119]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[120]  T. Crow,et al.  Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. , 1993, American journal of medical genetics.

[121]  A. Gilfillan,et al.  Prenatal cystic fibrosis carrier screening: Factors in a woman's decision to decline testing , 1993, Prenatal diagnosis.

[122]  Peter J. Schwartz,et al.  Diagnostic Criteria for the Long QT Syndrome An Update , 1993, Circulation.

[123]  C. Mathew,et al.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull? , 1993, BMJ.

[124]  E. Andolf Ultrasound Screening in Women at Risk for Ovarian Cancer , 1993, Clinical obstetrics and gynecology.

[125]  D. S. St. John,et al.  Cancer Risk in Relatives of Patients with Common Colorectal Cancer , 1993, Annals of Internal Medicine.

[126]  M. Piver,et al.  Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry , 1993, Cancer.

[127]  A. Howell,et al.  Perception of risk in women with a family history of breast cancer. , 1993, British Journal of Cancer.

[128]  R. Axton,et al.  A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet , 1993, Clinical genetics.

[129]  A. Martinuzzi,et al.  Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[130]  N. Carter,et al.  Analysis of chromosome 21 copy number in uncultured amniocytes by fluorescence in situ hybridization using a cosmid contig , 1992, Prenatal diagnosis.

[131]  P. Hartge,et al.  Age at onset for familial epithelial ovarian cancer , 1992, JAMA.

[132]  P. Beer-Romero,et al.  The human Y chromosome: a 43-interval map based on naturally occurring deletions. , 1992, Science.

[133]  K. Kerlikowske,et al.  Should women with familial ovarian cancer undergo prophylactic oophorectomy? , 1992, Obstetrics and gynecology.

[134]  A. Weber,et al.  SEROUS CARCINOMA OF THE PERITONEUM AFTER OOPHORECTOMY , 1992, Obstetrics and gynecology.

[135]  T. Crow Sexual selection, ‘machiavellian’ intelligence and the origins of psychosis , 1992, European Neuropsychopharmacology.

[136]  D. Donnai,et al.  Ovarian cancer family and prophylactic choices. , 1992, Journal of Medical Genetics.

[137]  I. Nonaka,et al.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[138]  V. Park,et al.  The presence of interstitial telomeric sequences in constitutional chromosome abnormalities. , 1992, American journal of human genetics.

[139]  H. Willard,et al.  Beta satellite DNA: characterization and localization of two subfamilies from the distal and proximal short arms of the human acrocentric chromosomes. , 1992, Genomics.

[140]  M. Zeviani,et al.  Neurological disorders due to mutations of the mitochondrial genome , 1991, Neuromuscular Disorders.

[141]  N. Wald Couple screening for cystic fibrosis , 1991, The Lancet.

[142]  R. Williamson,et al.  Screening for carriers of cystic fibrosis through primary health care services. , 1991, BMJ.

[143]  S. Loader,et al.  Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model. , 1991, American journal of human genetics.

[144]  S. Michie,et al.  Perceived risk not actual risk predicts uptake of amniocentesis , 1991, British journal of obstetrics and gynaecology.

[145]  Bowman Je Prenatal screening for hemoglobinopathies. , 1991 .

[146]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[147]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[148]  Robin Lovell-Badge,et al.  A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif , 1990, Nature.

[149]  D. Love,et al.  Chromosome Abnormalities and Genetic Counselling , 1990 .

[150]  R. Hitchings Mitochondrial myopathies. , 1989, BMJ.

[151]  L. Shaffer,et al.  Chromosome Abnormalities and Genetic Counseling , 1989 .

[152]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[153]  J. Weissenbach,et al.  A sex chromosome rearrangement in a human XX male caused by Alu—Alu recombination , 1987, Cell.

[154]  M. Schwartz,et al.  Assignment of the locus order DXS28‐ DXS67‐DMD as a spin‐off from diagnostic DNA marker analysis in a family with Duchenne muscular dystrophy , 1987, Clinical genetics.

[155]  A. Emery,et al.  Human Cytogenetics. A Practical Approach , 1987 .

[156]  J. Ott,et al.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. , 1985, American journal of human genetics.

[157]  S. Yorifuji,et al.  Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Ql0 in Kearns‐Sayre syndrome , 1985, Neurology.

[158]  E. McKay,et al.  A familial insertion involving an active nucleolar organiser within chromosome 12. , 1984, Journal of medical genetics.

[159]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[160]  M. Becker,et al.  The Health Belief Model: A Decade Later , 1984, Health education quarterly.

[161]  J. Tobacman,et al.  INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES , 1982, The Lancet.

[162]  S. Nanko Schizophrenia‐like Psychosis in a 46, XX Male , 1981, Folia psychiatrica et neurologica japonica.

[163]  P. Henkind,et al.  Bilateral corneal dermis-like choristomas; an X chromosome-linked disorder. , 1981, Archives of ophthalmology.

[164]  M. Cohen,et al.  The identification of Y chromosome translocations following Distamycin A treatment , 1981, Clinical Genetics.

[165]  F. O'Donnell,et al.  Ring dermoid syndrome. A new syndrome of autosomal dominantly inherited, bilateral, annular limbal dermoids with corneal and conjunctival extension. , 1980, Archives of ophthalmology.

[166]  Kenneth A. Wallston,et al.  Development of the Multidimensional Health Locus of Control (MHLC) Scales , 1978, Health education monographs.

[167]  N. Seeman,et al.  Three-Dimensional Tertiary Structure of Yeast Phenylalanine Transfer RNA , 1974, Science.

[168]  A. Friedman,et al.  Bilateral corneal dermoids. , 1973, American journal of ophthalmology.

[169]  I. Rosenstock Why people use health services. , 1966, The Milbank Memorial Fund quarterly.

[170]  M. Ferguson-Smith X-Y chromosomal interchange in the aetiology of true hermaphroditism and of XX Klinefelter's syndrome. , 1966, Lancet.

[171]  C. Romano CONGENITAL CARDIAC ARRHYTHMIA. , 1965, Lancet.

[172]  Ward Oc A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964 .

[173]  A. Jervell,et al.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death , 1957 .

[174]  Salma K. Marani,et al.  Oncology nurses' knowledge, practice, and educational needs regarding cancer genetics. , 2001, American journal of medical genetics.

[175]  P. Butow,et al.  Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer. , 2000, Journal of Medical Genetics.

[176]  J. Vuust,et al.  High‐throughput single‐strand conformation polymorphism analysis by automated capillary electrophoresis: Robust multiplex analysis and pattern‐based identification of allelic variants , 1999, Human mutation.

[177]  F. Kaplan Tay-Sachs disease carrier screening: a model for prevention of genetic disease. , 1998, Genetic testing.

[178]  Yusuke Nakamura,et al.  Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome , 1998, Human Genetics.

[179]  W. Grody,et al.  Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style. , 1997, Women's Health.

[180]  T. Marteau,et al.  Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[181]  I. Lerer,et al.  Cystic Fibrosis Heterozygote Screening in the Orthodox Community of Ashkenazi Jews: The Dor Yesharim Approach and Heterozygote Frequency , 1996, European journal of human genetics : EJHG.

[182]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[183]  K. Calzone,et al.  Readers comment on the nursing role in cancer genetics. , 1995, Oncology Nursing Forum.

[184]  T. Crow,et al.  Schizophrenia and sex chromosome anomalies. , 1994, Schizophrenia bulletin.

[185]  M. de Braekeleer Prenatal screening for cystic fibrosis. , 1994, The Lancet.

[186]  M. Schwartz,et al.  Screening for Carriers of Cystic Fibrosis among Pregnant Women: A Pilot Study , 1993, European journal of human genetics : EJHG.

[187]  A. Smith,et al.  A 15p+ variant shown to be a t(Y;15) with fluorescence in situ hybridisation. , 1992, Annales de genetique.

[188]  L. Brown,et al.  Exchange of terminal portions of X- and Y-chromosomal short arms in human XX males , 1987, Nature.

[189]  M. Becker,et al.  Sociologic studies in human genetics. I. Compliance factors in a voluntary heterozygote screening program. , 1974, Birth defects original article series.

[190]  O. C. Ward A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964, Journal of the Irish Medical Association.